RICHARD H SCHELLER
CIK 1214133 · See Remarks · last filed 2026-06-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.86M
Companies
8
Total Filings
82
Lifetime Open-Market Net
-$26.47M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALEC | Director | 134,899 | $1.52 | $205.0K | -$2.39M | 16 | 2026-06-17 |
| MAZE | Director | 0 | $27.88 | $0 | -$464.0K | 3 | 2026-06-10 |
| Chrome Holding Co. (ME) Delisted | Director | 44,798 | $0.61 | $27.2K | -$59.7K | 6 | 2024-08-28 |
| DICE Therapeutics, Inc. (DICE) Delisted | Director | 0 | $47.55 | $0 | -$3.24M | 4 | 2023-08-09 |
| BBIO | Director | 55,126 | $85.55 | $4.72M | -$9.47M | 16 | 2023-02-21 |
| ORIC | Director | 40,423 | $11.91 | $481.4K | -$275.8K | 7 | 2021-05-24 |
| XENE | Director | 7,000 | $64.94 | $454.6K | $19.9K | 7 | 2019-09-18 |
| DNA | EVP-RESEARCH | 0 | $7.70 | $0 | -$10.60M | 19 | 2008-07-18 |
Recent Filings · Page 2 of 9
82 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-08-23 | ALEC | Sell (S) | −44,250 | -$228.4K | EDGAR |
| 2024-08-22 | ALEC | Notice (144) | −44,250 | -$210.2K | EDGAR |
| 2024-06-12 | ALEC | Grant (A) | +35,000 | $0 | EDGAR |
| 2024-02-14 | ALEC | Grant (A) | +8,541 | $0 | EDGAR |
| 2023-09-08 | Chrome Holding Co. (ME) Delisted | Grant (A) | +165,088 | $0 | EDGAR |
| 2023-08-09 | DICE Therapeutics, Inc. (DICE) Delisted | Disp (D) | −8,427 | $0 | EDGAR |
| 2023-06-15 | ALEC | Grant (A) | +26,250 | $0 | EDGAR |
| 2023-05-09 | DICE Therapeutics, Inc. (DICE) Delisted | Sell (S) | −84,097 | -$3.24M | EDGAR |
| 2023-05-05 | — | Notice (144) | −84,097 | -$3.24M | EDGAR |
| 2023-02-21 | BBIO | Mixed | +1,892 | -$16.5K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.